Ron Sugar

(Dr. Ronald Sugar Ph.D.)

Currently holds positions in Uber Technologies Inc, Amgen Inc, Apple Inc and Chevron Corp

Positions
Position Company Period
Independent Chairperson of the Board Uber Technologies Inc July 1, 2018 -
Independent Director Amgen Inc July 22, 2010 -
Independent Director Apple Inc Nov. 17, 2010 -
Lead Independent Director Chevron Corp Jan. 1, 2015 -
Independent Director Air Lease Corp April 1, 2010 - May 1, 2020
Independent Director Chevron Corp April 27, 2005 - Jan. 1, 2015
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-05-12 2021-05-12
US Amgen Inc (AMGN)
PS Planned sale
1,000 -5.9%
250.59
250,590 USD 		1,000 -5.9% 250.59 250,590 USD
2021-04-15 2021-04-14
US Amgen Inc (AMGN)
PS Planned sale
1,000 -5.9%
249.98
249,980 USD 		1,000 -5.9% 249.98 249,980 USD
2021-03-10 2021-03-10
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
231.53
231,530 USD 		1,000 -6.0% 231.53 231,530 USD
2021-02-10 2021-02-10
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
238.40
238,400 USD 		1,000 -6.0% 238.40 238,400 USD
2021-01-14 2021-01-13
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
235.99
235,990 USD 		1,000 -6.0% 235.99 235,990 USD
2020-08-19 2020-08-19
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
241.02
241,020 USD 		1,000 -6.0% 241.02 241,020 USD
2020-07-22 2020-07-22
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
259.79
259,790 USD 		1,000 -6.0% 259.79 259,790 USD
2020-06-17 2020-06-17
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.0%
228.54
228,540 USD 		1,000 -6.0% 228.54 228,540 USD
2020-05-20 2020-05-20
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.1%
229.27
229,270 USD 		1,000 -6.1% 229.27 229,270 USD
2020-04-22 2020-04-22
US Amgen Inc (AMGN)
PS Planned sale
1,000 -6.4%
233.35
233,350 USD 		1,000 -6.4% 233.35 233,350 USD
2019-11-07 2019-11-06
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
215.45
430,900 USD 		2,000 -12.2% 215.45 430,900 USD
2019-10-03 2019-10-02
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
193.58
387,160 USD 		2,000 -12.2% 193.58 387,160 USD
2019-09-04 2019-09-04
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
206.70
413,400 USD 		2,000 -12.2% 206.70 413,400 USD
2019-08-08 2019-08-07
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
183.04
366,080 USD 		2,000 -12.2% 183.04 366,080 USD
2019-07-08 2019-07-03
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.2%
187.58
375,160 USD 		2,000 -12.2% 187.58 375,160 USD
2019-06-05 2019-06-05
US Amgen Inc (AMGN)
PS Planned sale
2,000 -12.3%
175.68
351,360 USD 		2,000 -12.3% 175.68 351,360 USD
2019-05-03 2019-05-01
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
175.73
351,460 USD 		2,000 -13.3% 175.73 351,460 USD
2019-04-03 2019-04-03
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
193.18
386,360 USD 		2,000 -13.3% 193.18 386,360 USD
2019-03-08 2019-03-06
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
188.88
377,760 USD 		2,000 -13.3% 188.88 377,760 USD
2019-02-11 2019-02-07
US Amgen Inc (AMGN)
PS Planned sale
2,000 -13.3%
190.00
380,000 USD 		2,000 -13.3% 190.00 380,000 USD